Evidence map›Paper›PMID 42211298›Full record

ArticleFrontiers in neurology

Early recognition of post-stroke spasticity: the I-REFER study.

Klemens Fheodoroff, Benjamin Waeschle, Manuela Schuetzer, Georg Comes, Joerg Wissel

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06381999 (Initial Assessment of the Validity and Inter-Rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06381999 completednot on this map

Initial Assessment of the Validity and Inter-Rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool

TypeobservationalSponsorMerz Therapeutics GmbHRan2023 to 2024Enrolled70ConditionsPost-stroke Spasticity
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Klemens FheodoroffKABEG Gailtal-Klinik, Neurorehabilitation, Hermagor, Austria.
Benjamin WaeschleMerz Therapeutics GmbH, Frankfurt, Germany.
Manuela SchuetzerMerz Pharma Austria GmbH, Vienna, Austria.
Georg ComesMerz Therapeutics GmbH, Frankfurt, Germany.
Joerg WisselNeurology and Psychosomatics at Wittenbergplatz, Out-Patient Clinic, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Effective post-stroke spasticity (PSS) management relies on early recognition and treatment, but access to specialist physicians is limited and PSS remains underdiagnosed and undertreated. Empowering non-specialist nurses and therapists to identify potential harmful PSS may expedite appropriate referral. We assessed validity and inter-rater reliability (IRR) of the spastic movement disorders decision tree for upper extremity spasticity by comparing referral decisions made by nurses and therapists to those made by specialist physicians (https://clinicaltrials.gov/study/NCT06381999). Methods: The decision tree evaluates three cardinal symptoms of PSS at the elbow, wrist, and fingers using simplified versions of standard scales. Nurses and physio-/occupational therapists used the decision tree to rate each symptom as "no/minimal," "moderate," or "severe," resulting in a dichotomous outcome of referral/no-referral to a specialist. Referral decisions ( Results: IRR was high between nurses and physicians on the need for specialist referral, overall (85.5%) and at the elbow (88.4%), wrist (85.5%), and fingers (84.1%), with 84.6% sensitivity (to correctly identify patients requiring specialist referral) and 86.7% specificity (to identify those not requiring specialist referral). Positive and negative predictive values were also high overall (89.2 and 81.3%, respectively) and at all (movement) segments. Findings were similar for therapists versus physicians. Sensitivity analyses based on a categorical endpoint (low risk for PSS, assess botulinum toxin type A [BoNT-A] indication, indication for BoNT-A) showed similar trends, although IRR versus physicians was lower for both nurses and therapists compared with dichotomous results. Conclusion: This decision tree for spasticity in the upper extremities showed high validity and reliability for effectively helping nurses and therapists recognize potential PSS and initiate specialist referral for timely diagnosis and potential BoNT-A treatment. It is recommended that this tool be introduced into standard clinical practice and its potential for broader use in community settings be examined.

Indexed as

botulinum neurotoxin type A [MeSH term]decision tree [MeSH term]early recognitionmuscle spasticity [MeSH term]nursespost-stroke spasticitystroke [MeSH term]therapists

Identifiers

PMID42211298
PMCPMC13215129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.